SC
WST icon

SouthState Corp’s West Pharmaceutical WST Stock Holding History

SouthState Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Hold
63
– – ﹤0.01% 596
2026
Q1 		$15.8K Sell
63
-35
-36% -$8.71K ﹤0.01% 596
2025
Q4 		$27K Buy
98
+35
+56% +$9.57K ﹤0.01% 541
2025
Q3 		$16.5K Sell
63
-9
-13% -$2.19K ﹤0.01% 596
2025
Q2 		$15.8K Buy
72
+67
+1,340% +$14.3K ﹤0.01% 698
2025
Q1 		$1.12K Buy
+5
New +$1.38K ﹤0.01% 1310
2024
Q3 		– Sell
-12
Closed -$3.95K – 655
2024
Q2 		$3.95K Buy
+12
New +$4.24K ﹤0.01% 551

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SouthState Corp's WST Position: Q2 2026 in Review

SouthState Corp held its West Pharmaceutical (WST) position steady in Q2 2026 at 63 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #596.

SouthState Corp first reported a position in WST in Q2 2024 and has held it in 7 quarters since. The position peaked at $27K in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • SouthState Corp held 63 shares of West Pharmaceutical worth $22.6K as of Q2 2026.
  • SouthState Corp left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #596 holding.
  • SouthState Corp first reported a position in West Pharmaceutical in Q2 2024 and has held it in 7 quarters since.
  • SouthState Corp's West Pharmaceutical position peaked at $27K in Q4 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.